Sunday - May 11, 2025

LOGIN  |  REGISTER

Recent Insider Transactions - Edgewise Therapeutics (NASDAQ: EWTX)

Follow NASDAQ:EWTX Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ EWTX Edgewise Therapeutics
Russell Alan J / director, officer: Chief Scientific Officer
05/02/2025
Sell
$16.45
1,551
$26K
18,521
NASDAQ EWTX Edgewise Therapeutics
MOORE JOHN R / officer: General Counsel
05/02/2025
Sell
$16.45
1,930
$32K
6,531
NASDAQ EWTX Edgewise Therapeutics
KOCH KEVIN / director, officer: President and CEO
05/02/2025
Sell
$16.45
4,276
$70K
20,619
NASDAQ EWTX Edgewise Therapeutics
Donovan Joanne M. / officer: CMO
05/02/2025
Sell
$16.45
5,187
$85K
21,588
NASDAQ EWTX Edgewise Therapeutics
Derakhshan Behrad / officer: Chief Business Officer
05/02/2025
Sell
$16.45
1,691
$28K
20,355
NASDAQ EWTX Edgewise Therapeutics
Carruthers R Michael / officer: Chief Financial Officer
05/02/2025
Sell
$16.45
1,314
$22K
81,014
NASDAQ EWTX Edgewise Therapeutics
Thompson Peter A. / director, 10 percent owner:
04/03/2025
Buy
$20.13
372,578
$7.500M
14.81M
NASDAQ EWTX Edgewise Therapeutics
Thompson Peter A. / director, 10 percent owner:
04/03/2025
Buy
$20.13
124,193
$2.500M
443,792
NASDAQ EWTX Edgewise Therapeutics
ORBIMED ADVISORS LLC / director, 10 percent owner:
04/03/2025
Buy
$20.13
372,578
$7.500M
14.81M
NASDAQ EWTX Edgewise Therapeutics
ORBIMED ADVISORS LLC / director, 10 percent owner:
04/03/2025
Buy
$20.13
124,193
$2.500M
443,792

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous